References
Aug 1, 1992·Psychological Medicine·A Buchanan
Nov 1, 1991·Statistics in Medicine·A Whitehead, J Whitehead
Aug 15, 1997·Biological Psychiatry·L A Arvanitis, B G Miller
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Feb 16, 1999·Schizophrenia Research·S LeuchtW Kissling
Jan 6, 2000·Psychiatry Research·J PeuskensW Rein
Jun 28, 2000·International Clinical Psychopharmacology·R A EmsleyA M Jones
Dec 1, 2000·BMJ : British Medical Journal·J GeddesP Bebbington
May 15, 2001·BMJ : British Medical Journal·P Jacobsen
Sep 5, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A Aleman, R S Kahn
Dec 18, 2001·Biological Psychiatry·P F Buckley
Jan 31, 2002·The Journal of Clinical Psychiatry·J M Davis, N Chen
Dec 31, 2002·Psychoneuroendocrinology·R Tandon, U Halbreich
Feb 12, 2004·CNS Drugs·Susan M Cheer, Antona J Wagstaff
Citations
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Nov 24, 2005·Journal of Psychiatric Practice·Simon C Burton
Nov 12, 2005·Journal of Clinical Psychopharmacology·Stephen StathisJames G McKenna
Nov 16, 2007·Journal of Clinical Psychopharmacology·Matthew ByerlyRoss A Baker
Jun 4, 2010·Journal of Clinical Psychopharmacology·Falk W LohoffKarl Rickels
Feb 28, 2008·International Clinical Psychopharmacology·Hans-Jürgen MöllerUNKNOWN Study 146 Investigators
Nov 16, 2012·Neuropsychiatric Disease and Treatment·Nizar El-Khalili
Feb 1, 2007·Neuropsychiatric Disease and Treatment·Pierre Chue
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Michael RiedelHans-Jürgen Möller
Dec 31, 2010·Indian Journal of Pharmacology·Ruchita ShahNidhi Malhotra
Jan 5, 2014·Clinical Pharmacokinetics·Qian LiTian Mei Si
Jun 24, 2014·Journal of Child and Adolescent Psychopharmacology·Robert L FindlingMelissa P DelBello
Jan 1, 2007·International Journal of Psychiatry in Clinical Practice·Juan Gibert For The Sos Group 1
Oct 18, 2011·Expert Opinion on Pharmacotherapy·Leslie Citrome
Nov 26, 2014·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Jul 13, 2006·Current Medical Research and Opinion·Stéphane PotvinAlain Gendron
Feb 27, 2016·General Hospital Psychiatry·Inbal Shlomi PolachekSimone N Vigod
Dec 21, 2006·Journal of Clinical Pharmacy and Therapeutics·I R De Oliveira, M F Juruena
Oct 5, 2010·Journal of Affective Disorders·Michael BauerHans Eriksson
May 28, 2011·L'Encéphale·F-J BayléP-M Llorca
May 6, 2008·Journal of Anxiety Disorders·M A KatzmanA Gendron
Mar 27, 2007·Journal of Affective Disorders·Caleb M AdlerStephen M Strakowski
Dec 24, 2008·Expert Review of Neurotherapeutics·Samuel Keith
Dec 20, 2007·Expert Review of Neurotherapeutics·Maurizio PompiliPaolo Girardi
Jun 20, 2015·Frontiers in Endocrinology·Megan Elizabeth Rich, Heather Kingsley Caldwell
Feb 11, 2015·Experimental and Therapeutic Medicine·Márcio G Soeiro-DE-SouzaRicardo Alberto Moreno
Feb 24, 2010·The International Journal of Neuropsychopharmacology·Nizar El-KhaliliHans Eriksson
Jan 16, 2014·The International Journal of Neuropsychopharmacology·Timm B PoepplMichael Landgrebe
Jul 3, 2013·The International Journal of Neuropsychopharmacology·Svante NybergLars Farde
Mar 9, 2017·Expert Opinion on Drug Discovery·Aline Silva de MirandaAntônio Lúcio Teixeira
Jul 28, 2007·Journal of Psychopharmacology·Beverley R TwaitesSaad A W Shakir
Oct 19, 2006·Journal of Psychopharmacology·Simon Burton
May 10, 2007·Human Psychopharmacology·Giuseppina Boidi, Maurizio Ferro
May 6, 2014·CNS Drugs·Rachel HershenbergOlga Brawman-Mintzer
Apr 29, 2020·Pharmacotherapy·Constance L ChowAmy M VandenBerg
Oct 31, 2014·International Clinical Psychopharmacology·Siegfried KasperMario Di Fiorino
May 10, 2012·Therapeutic Drug Monitoring·Shen-Chieh ChangTzu-Hua Wu
Oct 21, 2015·CNS Drugs·Henk Temmingh, Dan J Stein
Aug 16, 2018·MedChemComm·Maria AzmanovaNicolas P E Barry
May 15, 2018·Medicines·Peggy BoschMaurits Van den Noort
Dec 13, 2007·CNS Drugs·Anna SparshattDavid Taylor